SI2001445T1 - Farmacevtski sferoidi - Google Patents

Farmacevtski sferoidi

Info

Publication number
SI2001445T1
SI2001445T1 SI200731538T SI200731538T SI2001445T1 SI 2001445 T1 SI2001445 T1 SI 2001445T1 SI 200731538 T SI200731538 T SI 200731538T SI 200731538 T SI200731538 T SI 200731538T SI 2001445 T1 SI2001445 T1 SI 2001445T1
Authority
SI
Slovenia
Prior art keywords
spheroids
pharmaceutical
pharmaceutical spheroids
Prior art date
Application number
SI200731538T
Other languages
English (en)
Inventor
Helen Kathleen Danagher
Geoffrey Gerard Hayes
Hassan Mohammad
Malcolm Walden
Jonathon Oliver Whitehouse
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0605271A external-priority patent/GB0605271D0/en
Priority claimed from GB0605542A external-priority patent/GB0605542D0/en
Priority claimed from GB0617272A external-priority patent/GB0617272D0/en
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of SI2001445T1 publication Critical patent/SI2001445T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200731538T 2006-03-16 2007-03-16 Farmacevtski sferoidi SI2001445T1 (sl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0605271A GB0605271D0 (en) 2006-03-16 2006-03-16 Pharmaceutical spheroids
GB0605542A GB0605542D0 (en) 2006-03-20 2006-03-20 Pharmaceutical Spheroids
GB0617272A GB0617272D0 (en) 2006-09-04 2006-09-04 Pharmaceutical spheroids
EP07733554.5A EP2001445B1 (en) 2006-03-16 2007-03-16 Pharmaceutical spheroids
PCT/GB2007/050129 WO2007105016A1 (en) 2006-03-16 2007-03-16 Pharmaceutical spheroids

Publications (1)

Publication Number Publication Date
SI2001445T1 true SI2001445T1 (sl) 2015-02-27

Family

ID=38191129

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200731538T SI2001445T1 (sl) 2006-03-16 2007-03-16 Farmacevtski sferoidi

Country Status (13)

Country Link
US (1) US9034373B2 (sl)
EP (1) EP2001445B1 (sl)
JP (2) JP5443768B2 (sl)
CY (1) CY1115770T1 (sl)
DK (1) DK2001445T3 (sl)
ES (1) ES2516693T3 (sl)
HR (1) HRP20141001T1 (sl)
ME (1) ME02135B (sl)
PL (1) PL2001445T3 (sl)
PT (1) PT2001445E (sl)
RS (1) RS53624B1 (sl)
SI (1) SI2001445T1 (sl)
WO (1) WO2007105016A1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2001445B1 (en) * 2006-03-16 2014-07-23 Euro-Celtique S.A. Pharmaceutical spheroids
AT511581A1 (de) 2011-05-26 2012-12-15 G L Pharma Gmbh Orale retardierende formulierung
FR3080278B1 (fr) * 2018-04-11 2021-04-30 Ghs Patents Ltd Procede de fabrication d'un spheroide de cannabidiol

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471784A1 (fr) * 1979-12-21 1981-06-26 Roussel Uclaf Medicaments antiarythmiques a action prolongee dont le principe actif est le a/2-/bis (1-methylethyl) amino/ethyl/-a-phenyl-2-pyridine acetamide ou ses sels, ainsi que le procede de preparation de ces nouveaux medicaments et compositions les renfermant
GB8626098D0 (en) 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
DE69429710T2 (de) * 1993-11-23 2002-08-08 Euro Celtique Sa Verfahren zur Herstellung einer Arzneizusammensetzung mit verzögerter Wirkstoffabgabe
DE4415921A1 (de) 1994-05-05 1995-11-09 Bayerische Motoren Werke Ag Vorrichtung zum Dämpfen von Schwingungen in einer Getriebeschaltvorrichtung für Fahrzeuge
EP0762869A1 (en) * 1994-06-03 1997-03-19 The Procter & Gamble Company Fast dissolving dosage forms
US5458823A (en) 1994-10-28 1995-10-17 Fuisz Technologies Ltd. Method and apparatus for spinning feedstock material
ES2210321T3 (es) * 1994-12-19 2004-07-01 Daiichi Pharmaceutical Co., Ltd. Preparacion granular de liberacion prolongada y procedimiento de produccion.
EP0826376B1 (en) 1995-05-02 2007-01-24 Taisho Pharmaceutical Co. Ltd Composition for oral administration
WO1997003656A1 (fr) 1995-07-21 1997-02-06 Daiichi Pharmaceutical Co., Ltd. Preparation granulaire et son procede de production
JP5042447B2 (ja) * 1995-07-21 2012-10-03 第一三共株式会社 混合製剤
US5851454A (en) 1997-06-13 1998-12-22 Fuisz Technologies, Ltd. Spinner head having flow restricting inserts
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
US6117452A (en) 1998-08-12 2000-09-12 Fuisz Technologies Ltd. Fatty ester combinations
WO2000054811A1 (fr) * 1999-03-17 2000-09-21 Daiichi Pharmaceutical Co., Ltd. Compositions medicamenteuses
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
ES2261643T3 (es) 2001-02-13 2006-11-16 Astrazeneca Ab Nueva formulacion de liberacion modificada.
WO2004064807A1 (en) 2003-01-23 2004-08-05 Amorepacific Corporation Sustained-release preparations and method for producing the same
US20060251724A1 (en) * 2003-05-06 2006-11-09 Farrell Thomas P Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutical dosage forms and methods of preparing the same
EP2001445B1 (en) * 2006-03-16 2014-07-23 Euro-Celtique S.A. Pharmaceutical spheroids

Also Published As

Publication number Publication date
HRP20141001T1 (hr) 2014-12-05
EP2001445A1 (en) 2008-12-17
DK2001445T3 (da) 2014-10-27
ES2516693T3 (es) 2014-10-31
PT2001445E (pt) 2014-10-24
CY1115770T1 (el) 2017-01-25
JP2014088363A (ja) 2014-05-15
ME02135B (me) 2015-04-30
EP2001445B1 (en) 2014-07-23
JP5443768B2 (ja) 2014-03-19
US20100047337A1 (en) 2010-02-25
WO2007105016A1 (en) 2007-09-20
JP2009530258A (ja) 2009-08-27
PL2001445T3 (pl) 2015-06-30
RS53624B1 (en) 2015-04-30
US9034373B2 (en) 2015-05-19

Similar Documents

Publication Publication Date Title
EP1992348A4 (en) PHARMACEUTICAL COMBINATION
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
ZA200809546B (en) Pharmaceutical compounds
GB0608820D0 (en) Pharmaceutical compounds
GB0614586D0 (en) Pharmaceutical Formulation
ZA200806318B (en) Drug combinations
IL197883A0 (en) Combination drug
GB0625783D0 (en) Medicament
GB0600528D0 (en) Drug detector
GB0615064D0 (en) Medicament
GB0608184D0 (en) Pharmaceutical compounds
GB0608176D0 (en) Pharmaceutical Compounds
ME02135B (me) Farmaceutski sferoidi
GB0608264D0 (en) Pharmaceutical compounds
GB0608996D0 (en) Drug counter
GB0615814D0 (en) Medicament
GB0625682D0 (en) Pharmaceutical compounds
GB0622892D0 (en) Pharmaceutical compounds
GB0608175D0 (en) Pharmaceutical Compounds
ZA200708369B (en) Medicament
GB0617272D0 (en) Pharmaceutical spheroids
GB0605542D0 (en) Pharmaceutical Spheroids
GB0605271D0 (en) Pharmaceutical spheroids
GB0618135D0 (en) Novel pharmaceutical
GB0614457D0 (en) Pharmaceutical Combinations